Publications by authors named "A Adil Hismiogullari"

Background: Obesity has a significant impact on asthma incidence and control. Nesfatin-1, encoded by the nucleobindin-2 (NUCB2) gene, regulates energy balance. This study aimed to evaluate NUCB2 gene polymorphism (rs757081 C > G) and its association with serum levels of nesfatin-1 and inflammatory cytokines in obese and non-obese patients with asthma.

View Article and Find Full Text PDF

Hepcidin is a biomarker produced by hepatocytes in chronic disease anemia and is known to increase during chronic inflammation. This study compares the hepcidin levels in idiopathic pulmonary fibrosis (IPF) patients and controls, evaluating its relationship with anemia and systemic inflammation in IPF patients. This study included 82 IPF patients and 31 controls.

View Article and Find Full Text PDF

Oncostatin M, a novel adipokine, plays a role in oogenesis, lipogenesis, and inflammation and may contribute to polycystic ovary syndrome pathogenesis and related metabolic problems. Adipokines are believed to contribute to developing polycystic ovary syndrome and its accompanying metabolic parameters, such as dyslipidemia, insulin resistance, and cardiovascular diseases. In this case-control study, the patients were grouped in a 1:1 ratio into either the polycystic ovary syndrome ( 32) or the control group ( 32).

View Article and Find Full Text PDF

Neutrophil gelatinase-associated lipocalin (NGAL, also known as lipocalin-2) is an acute-phase protein expressed in many tissues and plays a role in cell proliferation, regulation, and epithelial-mesenchymal transformation. Therefore, this study aimed to investigate serum NGAL levels and endometrioma tissue expression in women with endometriosis. This cross-sectional study was conducted at a university hospital.

View Article and Find Full Text PDF
Article Synopsis
  • Acute lung injury (ALI) is a serious condition in intensive care, often studied using a model that involves lipopolysaccharide (LPS) to simulate lung damage, where this study examines the effects of treatments like tocilizumab, adalimumab, and methylprednisolone on LPS-induced ALI.
  • In this study, rats were given LPS to induce lung injury and then received different treatment regimens; histological and immunological analyses showed that both adalimumab and the combination of adalimumab and tocilizumab significantly improved lung structure and reduced inflammation markers compared to those treated with steroids alone.
  • The results indicate that adalimumab and/or tocilizumab are
View Article and Find Full Text PDF